Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03839043 · ClinicalTrials.gov registry record · NA
Short Messaging Service Program to Help Quit Smoking During Perioperative Period.
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03839043: Completed NA study, sponsored by Mayo Clinic.
NCT03839043 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03839043, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Smoking can increase the risk of complications around the time of surgery. Researchers are trying to see if a text messaging program can help smokers stay off cigarettes around the time of surgery.
Primary Outcome
Provides one measure of subject engagement in treatment - how many are willing to continue using the text messaging service after 30 days.
Interventions
- BEHAVIORAL Brief behavioral intervention
- OTHER SMS Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2021-06-11 |
| Phase | NA |
What the finished NCT03839043 record still lists
NCT03839043 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Brief behavioral intervention is the first listed.
NCT03839043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03839043 about?
NCT03839043 is a clinical study titled "Short Messaging Service Program to Help Quit Smoking During Perioperative Period.". Smoking can increase the risk of complications around the time of surgery. Researchers are trying to see if a text messaging program can help smokers stay off cigarettes around the time of surgery.
What is the current status of trial NCT03839043?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-03-18. Estimated completion is 2021-06-11.
What interventions are being tested in trial NCT03839043?
The interventions under investigation include: Brief behavioral intervention (BEHAVIORAL), SMS Program (OTHER).
Who is sponsoring clinical trial NCT03839043?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03839043's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI